ANDREW SPRINGER: Open Payments
NPI 1790967123 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 13 payments from 8 companies in 2025. Trend: 2023 $609 · 2024 $684 · 2025 $570
Food & beverage: $433Education: $137
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $158 |
| Medical Device Business Services, Inc. | 1 | $137 |
| Neurocrine BioSciences, Inc. | 1 | $127 |
| Novo Nordisk Inc | 3 | $54 |
| Boston Scientific Corporation | 1 | $41 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $15 |
Products named: STRATAFIX, AIRSUPRA, INGREZZA, WATCHMAN Access System, Ozempic, FARXIGA, SHINGRIX, MOUNJARO.
Industry payments across FL — which companies pay providers there.
